U
UCLB
Venture CapitalActiveUCLB is the commercialisation company of UCL that brings to market truly world-leading, world-changing technologies and innovations.
39
Investments
5
Exits
—
AUM
12.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for UCLB.
Investment Thesis & Strategy
UCLB invests in various stages of fintech companies with world-leading and world-changing technologies and innovations. As the commercialization company of UCL, they focus on bringing these technologies to market.
Investment Activity
Deals per year over the last 11 years
1
20111
20120
20131
20141
20150
20162
20170
20181
20193
20202
2021Portfolio Companies
Selected investments from their portfolio of 39 companies
T
Topolytics
Cleantech · Series A, 2021
V
VUI Diagnostics
Healthcare · Seed, 2021
B
Baseimmune
Biotech · Seed, 2020
H
Huma Therapeutics
Healthcare · Series B, 2020
i
iLoF
Biotech · Seed, 2020
P
PanTher Therapeutics
Biotech · Seed, 2019
H
Healx
Biotech · Series A, 2017
U
Ultromics
Healthcare · Series A, 2017
S
Synthace
Biotech · Series A, 2015
I
Inivata
Biotech · Series A, 2014
A
Autifony Therapeutics
Biotech · Series A, 2012
K
Kymab
Biotech · Series A, 2011
Frequently Asked Questions
UCLB focuses on Series A, Series B, Series C+ stage investments.